Serum cystatin C concentrations are reported to increase in the hyperthyroid state. Serum concentrations of cystatin C and transforming growth factor-β1 (TGF-β1) were measured in patients with thyroid dysfunction, and the effects of 3,5,3′-tri-iodothyronine (T3) and TGF-β1 on cystatin C production in human hepatoblastoma (Hep G2) cells were studied. Serum concentrations of cystatin C and TGF-β1 were significantly higher in patients with Graves' disease compared with control subjects. Significantly positive correlations were observed between thyroid hormones and cystatin C, thyroid hormones and TGF-β1, and TGF-β1 and cystatin C in patients with thyroid dysfunction. Serum concentrations of cystatin C and TGF-β1 decreased after treatment for hyperthyroidism. Cystatin C mRNA levels and cystatin C secretion were increased by T3 and TGF-β1 in cultured Hep G2 cells. These results suggest that serum cystatin C concentrations increase in patients with hyperthyroidism. The mechanisms for this may involve elevation of serum TGF-β1 levels and the stimulatory effects of T3 and TGF-β1 on cystatin C production.
AbrahamsonMBarrettAJSalvesenG: Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem1986; 261: 11282–11289.
2.
GrubbALöfbergH: Human γ-trace, a basic microprotein: Amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA1982; 79: 3024–3027.
3.
BarrettAJDaviesMEGrubbA: The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun1984; 120: 631–636.
4.
AbrahamsonMOlafssonIPalsdottirA: Structure and expression of the human cystatin C gene. Biochem J1990; 268: 287–294.
5.
NewmanDJThakkarHEdwardsRG: Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int1995; 47: 312–318.
6.
LaterzaOFPriceCPScottMG: Cystatin C: An improved estimator of glomerular filtration rate?Clin Chem2002; 48: 699–707.
7.
FillerGBökenkampAHofmannW: Cystatin C as a marker of GFR – history, indications, and future research. Clin Biochem2005; 38: 1–8.
8.
JayagopalVKeevilBGAtkinSL: Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism. Clin Chem2003; 49: 680–681.
9.
den HollanderJGWulkanRWMantelMJ: Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction?Clin Chem2003; 49: 1558–1559.
10.
WiesliPSchweglerBSpinasGA: Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta2003; 338: 87–90.
ShiGPSukhovaGKGrubbA: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest1999; 104: 1191–1197.
13.
SolemMRawsonCLindburgK: Transforming growth factor β regulates cystatin C in serum-free mouse embryo (SFME) cells. Biochem Biophys Res Commun1990; 172: 945–951.
14.
AfonsoSTovarCRomagnanoL: Control and expression of cystatin C by mouse decidual cultures. Mol Reprod Dev2002; 61: 155–163.
15.
SokolJPSchiemannWP: Cystatin C antagonizes transforming growth factor β signaling in normal and cancer cells. Mol Cancer Res2004; 2: 183–195.
16.
IchikawaKDeGrootLJ: Thyroid hormone receptors in a human hepatoma cell line: Multiple receptor forms on isoelectric focusing. Mol Cell Endocrinol1987; 51: 135–143.
17.
InagakiMWangZCarrBI: Transforming growth factor β1 selectively increases gene expression of the serine/threonine kinase receptor 1 (SKR1) in human hepatoma cell lines. Cell Struct Funct1994; 19: 305–313.
18.
SamuelsHHStanleyFCasanovaJ: Depletion of l-3,5,3′-triiodothyronine and l-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology1979; 105: 80–85.
19.
JibornTAbrahamsonMWallinH: Cystatin C is highly expressed in the human male reproductive system. J Androl2004; 25: 564–572.
20.
VerhelstJBerwaertsJMarescauB: Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction. Metabolism1997; 46: 1063–1067.
21.
FordHCLimWCChisnallWN: Renal function and electrolyte levels in hyperthyroidism: Urinary protein excretion and the plasma concentrations of urea, creatinine, uric acid, hydrogen ion and electrolytes. Clin Endocrinol (Oxf)1989; 30: 293–301.
22.
KapteinEM: The kidneys and electrolyte metabolism in thyrotoxicosis. In: Werner & Ingbar's the Thyroid: a Fundamental and Clinical Text, 9th edn (BravermanLEUtigerRD, eds). Philadelphia: Lippincott Williams & Wilkins, 2005; pp 582–588.
23.
KreismanSHHennesseyJV: Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med1999; 159: 79–82.
24.
LafayetteRACostaMEKingAJ: Increased serum creatinine in the absence of renal failure in profound hypothyroidism. Am J Med1994; 96: 298–299.
25.
AkinciBComlekciAYenerS: Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-β1 levels. Arch Med Res2008; 39: 397–401.
26.
YamadaHWatanabeMNanbaT: The +869T/C polymorphism in the transforming growth factor-β1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin Exp Immunol2008; 151: 379–382.
27.
YokotaMIchiharaSLinTL: Association of a T29→C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation2000; 101: 2783–2787.
